+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
ASARFI ASARFI

Asarfi Hospital Share Price

₹199.90 -0.75 (-0.37%)
62.52% Gain from 52W Low

10 Sep, 2026 4:01 PM (IST)

Asarfi Hospital live price: ₹199.90. It opened at ₹207 vs previous close ₹201; intraday high/low: ₹208/₹195. The 50 & 200 DMA stand at ₹212.50/₹194.60.

Asarfi Hospital Performance

  • Today's Low
  • ₹195
  • Today's High
  • ₹208
  • 52 Week Low
  • ₹123
  • 52 Week High
  • ₹257
  • Open Price₹207
  • Previous Close₹201
  • Volume57,000
  • 50 DMA₹212.50
  • 100 DMA₹209.00
  • 200 DMA₹194.60

Asarfi Hospital Chart

Investment Returns

  • Over 1 Month -9.89%
  • Over 3 Month -7.84%
  • Over 6 Month + 21.26%
  • Over 1 Year + 35.99%

Smart Investing Starts Here Start SIP with Asarfi Hospital for Steady Growth!

Invest Now

Asarfi Hospital Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 23.6
  • PEG Ratio
  • 0.5
  • Market Cap Cr
  • 393
  • P/B Ratio
  • 3.9
  • Average True Range
  • 10.7
  • EPS
  • 8.5
  • Dividend Yield
  • 0
  • MACD Signal
  • -7
  • RSI
  • 42.91
  • MFI
  • 24.76

Latest Stock News Updates

Asarfi Hospital Ltd - 543943 - Reg. 34 (1) Annual Report.

We hereby submit the Annual Report of Asarfi Hospital Limited for the Financial Year 2025-26, including the Notice convening the Annual General Meeting.

Asarfi Hospital Ltd - 543943 - Intimation Of Appointment Of Cost Auditor - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations. 2015.

We hereby inform you that the board of Director of the company at their meeting held on August 25, 2026 pursuant to the recommendation of the Audit Committee has approved the Appointment of M/s Ashutosh Kumar Sinha & Co, Cost Accountants, Dhanbad (Firms Registration No.004660) as Cost Accountant of the Company for the Financial Year 2026-27.

Asarfi Hospital Ltd - 543943 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements), 2015.

We hereby inform you that the meeting of the Board of Directors of Asarfi Hospital Limited was held on Tuesday, August 25, 2026 at 11:00 A.M. at the registered office of the Company at 4th Floor, Asarfi Hospital, Baramuri, B. Polytechnic, Dhanbad - 828130

Asarfi Hospital Financials

Asarfi Hospital Technicals

EMA & SMA

Current Price
₹199.90
-0.75 (-0.37%)
pointer
  • Bearish Moving Average 12
  • Bullish Moving Average 4
  • 20 Day
  • ₹207.50
  • 50 Day
  • ₹212.50
  • 100 Day
  • ₹209.00
  • 200 Day
  • ₹194.60

Resistance and Support

200.83 Pivot Speed
  • R3 218.30
  • R2 212.90
  • R1 205.90
  • S1 193.50
  • S2 188.10
  • S3 181.10

Asarfi Hospital Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-08-25 A.G.M.
2026-08-07 Quarterly Results
2026-05-11 Audited Results
2026-02-09 Quarterly Results
2025-08-20 A.G.M.

Asarfi Hospital Shareholding Pattern

61.17%
35.87%
2.97%

About Asarfi Hospital

Asarfi Hospital a public, integrated healthcare provider in India with two main facilities in Dhanbad, Jharkhand, offering a range of multi-specialty and tertiary care services, including cardiology, neurosciences, oncology, and critical care, with state-of-the-art infrastructure View More
  • NSE Symbol
  • ASARFI
  • BSE Symbol
  • 543943
  • ISIN
  • INE0DN001027

Similar Stocks to Asarfi Hospital

Asarfi Hospital FAQs

Asarfi Hospital share price is ₹199 As on 10 September, 2026 | 23:18

The Market Cap of Asarfi Hospital is ₹393.3 Cr As on 10 September, 2026 | 23:18

The P/E ratio of Asarfi Hospital is 23.6 As on 10 September, 2026 | 23:18

The PB ratio of Asarfi Hospital is 3.9 As on 10 September, 2026 | 23:18

The 52 week High & Low of Asarfi Hospital is ₹257/₹123 respectively As on 10 September, 2026 | 23:18

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23